Reuters logo
BRIEF-Catalyst Pharmaceuticals posts Q3 loss per share $0.05
2017年11月8日 / 晚上10点06分 / 16 天前

BRIEF-Catalyst Pharmaceuticals posts Q3 loss per share $0.05

Nov 8 (Reuters) - Catalyst Pharmaceuticals Inc

* Catalyst Pharmaceuticals announces third quarter 2017 financial results and provides corporate update

* Q3 GAAP loss per share $0.05

* Q3 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S

* Catalyst Pharmaceuticals Inc - ‍expects pre-commercialization expenses to increase in Q4 of 2017​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below